Did You Know...
...that the Band-Aid Bandage was invented by a Johnson & Johnson employee whose wife had cut herself? Earl Dickson's wife was rather accident prone, so he set out to develop a bandage that she could apply without help. He placed a small piece of gauze in the center of a small piece of surgical tape, and what we know today as the Band Aid bandage was born!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5795895 | Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug This is a new therapy and method used to treat moderate and severe exogenous obesity by combining generic phentermine with an SSRI (selective serotonin reuptake inhibitor) drug in specific doses for a brief or even a long duration, 12 months or more. The ... | 08/18/1998 |
| 5783603 | Potassium hydroxycitrate for the suppression of appetite and induction of weight loss The present invention provides methods of suppressing appetite and causing weight loss by administering to a patient hydroxy citric acid in the form of a potassium salt extracted from Garcinia fruit. Methods of inhibiting cytoplasmic citric lyase and incr... | 07/21/1998 |
| 5776906 | Method for promoting fat-degradation in fat cells For the purpose of providing a composition having an ability of promoting degradation of accumulated cellular fats, a substance having such ability was developed from naturally-occurring safe materials. Thus, according to the present invention, a composit... | 07/07/1998 |
| 5776983 | Catecholamine surrogates useful as ଲ3 agonists Compounds of the formula ##STR1## or pharmaceutically acceptable salts thereof wherein: A is a bond, --(CH2)n -- or --CH(B)--, where n is an integer of 1 to 3 and B is --CN, --CON(R9)R9' or --CO2... | 07/07/1998 |
| 5753253 | Composition and method for inducing satiety A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingre... | 05/19/1998 |
| 5747512 | Use of cotinine to alleviate tobacco withdrawal syndrome A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which ... | 05/05/1998 |
| 5744477 | Method for treatment of obesity using prolactin modulators and diet The present invention is directed to an improvement in a method of weight and/or body-fat reduction comprising a (preferably moderate) reduction in the caloric intake of a subject in need of such treatment in combination with administration to said subjec... | 04/28/1998 |
| 5726284 | Crosslinked polymric ammonium salts Disclosed are novel crosslinked polymeric ammonium salts wherein in said polymeric salt: about 25% or more of the segments which link ammonium nitrogen atoms are group Y wherein Y is an n-alkylene group or alkyl substituted n-alkylene group, wherein said ... | 03/10/1998 |
| 5719160 | Method for modifying and regulating lipid metabolism A process for the long term modification and regulation of lipid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of noninsulin dependent, or Type II diabete... | 02/17/1998 |
| 5709864 | Cosmetic or pharmaceutical and particularly dermatological, composition containing an extract of tephrosia, particularly Tephrosia purpurea The present invention relates to a cosmetic or a pharmaceutical composition, in particular a dermatological composition. The composition is characterized in that it comprises a cosmetically or pharmaceutically, and in particular dermatologically, effectiv... | 01/20/1998 |
| 5698199 | Lipolysis acceleration method The present invention provides a lipolysis acceleration method which comprises orally administering a thistle-series or pepper-family plant, or an extract thereof; or dermatologically applying it by local administration or as a bath medicine composition. ... | 12/16/1997 |
| 5646152 | Methods of administering CRF antagonists Compounds of the formula ##STR1## wherein B, R3, R4, R5 and R6 are as defined herein with reference to formula IX have corticotropin-releasing factor antagonist activity and as such are of use in the treatm... | 07/08/1997 |
| 5643874 | Pharmaceutical composition comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor A pharmaceutical composition containing a glucosidase and/or amylase inhibitor and a lipase inhibitor as active substances and usual pharmaceutical carriers.... | 07/01/1997 |
| 5637316 | Slimming composition for topical treatment, containing two types of liposomes, and use thereof Compositions containing a first dispersion of lipid vesicles which are capable of penetrating into the deep layers of the skin and which contain at least one active agent chosen from lipolytic agents, draining agents and firming agents, for treating these... | 06/10/1997 |
| 5610152 | Anti-obesity agent 4-cholesten-3-one The present invention provides an anti-obesity agent comprising 4-cholesten-3-one represented by the following formula: ##STR1## as an effective component. The anti-obesity agent of the present invention is useful because of inhibition effect of body... | 03/11/1997 |
| 5602164 | Anti-obesity drugs Obesity is treated by the administration to a subject of a compound having the general formula (I): R4 --(CH2)n --CO--N(R1)--CH(R2)--CO(--R3), wherein R1 represents H or CH3... | 02/11/1997 |
| 5591437 | Cosmetic or pharmeceutical composition containing a black horehound extract A black horehound extract is used to prepare a cosmetic or pharmaceutical composition, particularly a dermatological composition, for promoting skin pigmentation, preventing or delaying the growth of grey hairs, treating pigmentary disorders, reducing tri... | 01/07/1997 |
| 5587398 | Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor Novel meta substituted arylakylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin mediated nerve transmission (e.g. depression and obesity).... | 12/24/1996 |
| 5578613 | Methods for inhibiting weight gain or inducing weight loss A method of inhibiting weight gain or inducing or facilitating weight loss comprising administering to a human an effective amount of a compound having the formula ##STR1## wherein R1 and R3 are independently hydrogen, --CH... | 11/26/1996 |
| 5578614 | Methods for inhibiting weight gain or inducing weight loss A method of inhibiting weight gain or inducing or facilitating weight loss comprising administering to a human an effective amount of a compound having the formula ##STR1## wherein R1 and R3 are independently hydrogen, --CH... | 11/26/1996 |
| 5573774 | Nicotine metabolites, nicotine dependence and human body weight A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicot... | 11/12/1996 |
| 5567714 | Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y A method of inhibiting obesity, a physiological disorder associated with an excess of neuropeptide Y, or its symptoms comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R1 | 10/22/1996 |
| 5554623 | Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates A process for the long term modification and regulation of lipid and glucose metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these being the hallmarks of noninsulin dependent, or Type II diabete... | 09/10/1996 |
| 5540917 | Biomass lipase inhibitor useful for treating adiposity A pharmaceutical composition comprising at least one water insoluble crude fiber and at least one lipase inhibitor. The lipase inhibitor is present in an amount effective for treating adiposity. The lipase inhibitor is selected from lipstatin in pure form... | 07/30/1996 |
| 5527788 | Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent The invention describes a method and composition for treating obesity or related disorders in animals using an anorectic agent and dehydroepiandrosterone (DHEA). The composition effectively diminishes caloric intake, may alter metabolism, weight gain, or ... | 06/18/1996 |
| 5516516 | Method of preparing muira puama extract and its use for decreasing body fat percentage and increasing lean muscle mass A method, and related compositions, for reducing body fat percentage, increasing lean muscle mass and/or lowering cholesterol levels in individuals. The method consists of the ingestion of an extract derived from muira puama root, bark or other wood mater... | 05/14/1996 |
| 5498417 | Transdermal delivery of appetite suppressant drug A medical device for the transdermal delivery of an appetite suppressant drug wherein said device comprises a silicone-coated release layer, a coating containing a mixture of a pressure-sensitive adhesive, an appetite suppressant drug, a permeation enhanc... | 03/12/1996 |
| 5498424 | Method of treating obesity The present invention provides a simple, pharmacological method for treating obesity without risk of undesirable side effects. It has been discovered that intake of a megadose of a macrolide antibiotic creates an anorexigenic reaction in the human suffici... | 03/12/1996 |
| 5487894 | Composition of dehydrated powdered mung bean sprout and plant fiber for use as dietary supplement in healthcare A dietary supplement composition is disclosed which contains dehydrated mung bean sprout and beta-glucan enriched oat groat.... | 01/30/1996 |
| 5484593 | Diet composition comprising gymnema inodrum and a method for suppressing the absorption of saccharides A composition for suppressing the absorption of saccharides comprises a Gymnema inodrum extract. The extract is prepared by drying and then roasting the leaves of the Gymnema inodrum or by subjecting the leaves of Gymnema inodrum to extraction with hot wa... | 01/16/1996 |
| 5480657 | Composition comprising caffeine chromium and fructose for weight control and use thereof A composition for the prevention or treatment of weight gain, e.g., obesity, said composition comprising caffeine, fructose and chromium in an effective amount to prevent or treat weight loss. Also disclosed is a method for the prevention or treatment of ... | 01/02/1996 |
| 5474991 | Lipid metabolism improving medicinal composition This invention relates to a lipid metabolism improving medicinal composition containing a phosphoric acid diester compound of the formula or a pharmacologically acceptable salt thereof. ##STR1## wherein R1 and R2 are the same or... | 12/12/1995 |
| 5468734 | Prophylactic and remedial preparation for diseases attendant on hyperglycemia, and wholesome food A prophylactic and remedial preparation for a disease attendant on hyperglycemia, a preparation for depressing the rise in blood sugar, and a wholesome food separately include, as an active ingredient, at least one component selected from the group consis... | 11/21/1995 |
| 5462742 | Gel-forming liquid dietary fibre composition A dietary fibre composition comprising a water-soluble, nononic cellulose ether having a cloud point not higher than 35° C. in combination with a charged surfactant and optional additives in water, the ratio of surfactant to cellulose ether being 1:5 to ... | 10/31/1995 |
| 5453270 | Pharmaceutical composition and method for hypermetabolic weight loss There is disclosed a pharmaceutical composition and method for metabolic consumption of calories and weight loss. The pharmaceutical composition is a culture of brown adipose cells, preferably encapsulated in a porous growth matrix, and a semipermeable me... | 09/26/1995 |
| 5447953 | Biomasses to treat non-human animals The use of biomasses obtained in the fermentative production of lipase inhibitors, especially lipstatin, for the preparation of foodstuffs, feedstuffs, food additives, feed additives, feed supplements, medicinal feed premixes or medicaments for oral admin... | 09/05/1995 |
| 5426120 | Pharmaceutical composition containing γ-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders γ-Hydroxybutyric acid and its physiologically equivalent forms are useful in the treatment of the syndromes of abstinence, craving and dependence on drugs, drugs of abuse, psychotropics, stupefacient and/or psychoactive substances, nicotine, or nutrition... | 06/20/1995 |
| 5420121 | Use of 4-cholesten-3-one as an anti-obesity agent The present invention provides a method for using the anti-obesity agent comprising 4-cholesten-3-one represented by the following formula: ##STR1## as an effective component. The anti-obesity agent of the present invention is useful because of inhib... | 05/30/1995 |
| 5407684 | Use of DHEA as a medicinal Dehydroepiandrosterone (DHEA) has an immune response regulating effect in vertebrates to protect from morbid effect of infection and immune suppressive therapies. DHEA is also effective for use in treatment of alopecia. Protection results from a generaliz... | 04/18/1995 |
| 5376371 | Compositions for treating fat deposits in humans Pharmaceutical and cosmetic compositions for the treatment of superfluous fat deposits contain (a) vegetable active principles having adenylate cyclase agonistic activity or (b) vegetable active principles having antiphosphodiesterase activity or a combin... | 12/27/1994 |
